Tumour necrosis factor-α, interleukin-1β and interleukin-8 induce persistent mechanical nociceptor hypersensitivity

Pain

Volumn 96, Issue 1-2, 2002, Pages 89-97

  Sachs, Daniela ^a   Cunha, Fernando Queiroz ^a   Poole, Stephen ^b   Ferreira, Sérgio Henrique ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Interlukin 1 ; Interlukin 8; Persistent inflammatory hyperalgesia; Tumour necrosis factor

Indexed keywords

ATENOLOL; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; LATENT PERIOD; MALE; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION TIME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES; ANTINEOPLASTIC AGENTS; ATENOLOL; DRUG THERAPY, COMBINATION; HYPERALGESIA; INDOMETHACIN; INTERLEUKIN-1; INTERLEUKIN-8; MALE; NOCICEPTORS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036205398     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00433-X     Document Type: Article

References (36)

1. The role of NF-κB in the retinal neovascularization in the rat: Possible involvement of cytokine-induced neutrophil chemoattractant (CINC), a member of the interleukin-8 family
2. 2 in 3T3 fibroblasts
3. Brain-derived TNFα: Involvement in neuroplastic changes implicated in the conscious perception of persistent pain
4. Interleukin-8 as a mediator of sympathetic pain
5. The pivotal role of tumor necrosis factor α in the development of inflammatory hyperalgesia
6. Pharmacological modulation of secondary mediator systems - Cyclic AMP and cyclic GMP - On inflammatory hyperalgesia
7. Participation of sympathetic system in acetic acid-induced writhing in mice
8. Prostaglandins: Peripheral and central analgesia
9. 2+ dependent process
10. Central and peripheral antialgesic action of aspirin-like drugs
11. 2
12. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue
13. Induction, blockade and restoration of a persistent hypersensitive state
14. Sustained hyperalgesia in rats evoked by 15-hydroperoxyeicosatetraenoic acid is attenuated by the protein kinase inhibitor H-7
15. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes
16. Intraocular production of a cytokine (CINC) responsible for neutrophil infiltration in endotoxin induced uveits
17. Intravenous regional sympathetic block with guanethidine
18. Antisymphatetic drugs in limbs
19. Influences of algogenic substances and prostaglandins on the discharges of unmyelinated cutaneous nerve fibres identified as nociceptors
20. Painful peripheral states and sympathetic blocks
21. Effects of regional guanethidine infusion in certain painful states
22. The analgesic effects of quaternary analogues of morphine and nalorphine
23. Inhibition of forskolin-induced sensitization of frog skin nociceptor by the cyclic AMP-dependent protein kinase A antagonist H-89
24. Preserved acute pain and reduced neuropathic pain in mice lacking PKCγ
25. A peripheral sympathetic component in inflammatory hyperalgesia
26. Sensitization of nociceptors and its relation to sensation
27. Rat tumor necrosis factor-α: Expression in recombinant picia pastoris, purification, characterization and development of novel ELISA
28. Central nervous system plasticity and persistent pain
29. Interleukin-1 beta contributes to the inflammation-induced increase in nerve-growth factor levels and inflammatory hyperalgesia
30. 2 levels
31. Identification of a common receptor for three types of rat cytokine-induced neutrophil chemoattractants (CINCS)
32. + channels: Mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside
33. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia
34. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system
35. Mechanism of diclofenac analgesia: Direct blockade of inflammatory sensization
36. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78